The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors
Leukemic stem cells (LSCs) drive chemoresistance and relapse in acute myeloid leukemia. Here, the authors show that the splicing factor RBM17 supports LSCs through avoiding nonsense-mediated decay of pro-leukaemic factors such as the translation initiation factor EIF4A2.
Main Authors: | Lina Liu, Ana Vujovic, Nandan P. Deshpande, Shashank Sathe, Govardhan Anande, He Tian Tony Chen, Joshua Xu, Mark D. Minden, Gene W. Yeo, Ashwin Unnikrishnan, Kristin J. Hope, Yu Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-31155-0 |
Similar Items
-
Fluorouracil Selectively Enriches Stem-like Leukemic Cells in a Leukemic Cell Line
by: Ling Zhang, Song Yang, Yu-Juan He, Hui-Yuan Shao, Li Wang, Hui Chen, Yu-Jie Gao, Feng-Xian Qing, Xian-Chun Chen, Liu-Yang Zhao, Shi Tan
Published: (2010-01-01) -
Anti-leukemic activity of a four-plant mixture in a leukemic rat model
by: Mai M. Kabeel, et al.
Published: (2018-01-01) -
The Leukemic Fly: Promises and Challenges
by: Amani Al Outa, et al.
Published: (2020-07-01) -
Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells
by: Alejandro Pando, et al.
Published: (2018-10-01) -
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
by: Lars Velten, et al.
Published: (2021-03-01)